Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site
VERTEX PHARMACEUTICALS INCORPORATED (VRTX)

The QuantWave forecast for VRTX vertex pharmaceuticals incorporated

Vertex Pharmaceuticals Incorporated is a biotechnology company that specializes in the discovery, development, and commercialization of innovative medicines for the treatment of serious diseases. With its headquarters in Boston, Massachusetts, the company has established itself as a leader in the field of precision medicine, utilizing advanced scientific techniques to target specific genetic mutations underlying various disorders. Vertex is known for its groundbreaking therapies for cystic fibrosis, a life-threatening genetic disease affecting the lungs and digestive system. The company's research and development efforts also extend to other progressive diseases, such as alpha-1 antitrypsin deficiency and sickle cell disease. With a strong focus on collaboration and strategic partnerships, Vertex continually pushes the boundaries of scientific knowledge to deliver life-changing treatments to patients in need.

The graph shows the results of our forecasting system for VRTX. You can view historical price data with markers indicating where our system has signaled and where projected targets have been achieved. This demonstrates how our system's forecasts have performed in real market conditions.

We do not display all achieved goals on the graph; detailed information is available in the corresponding section on this page.

The graph is interactive. Hover over target icons to see when the forecast was created.

Access the VRTX Forecast

Stock ticker:
VRTX
Name: VERTEX PHARMACEUTICALS INCORPORATED
Sector: Healthcare
Investing Risk: MEDIUM
Forecast length: 7 days
Accuracy: 46.08 %
Average profit per target: 4.48 %


VRTX Achieves Targets with Precision, as Predicted by QuantWave

Show news about the achieved forecast.

Signal Date Signal Price Date Reached Price Reached Profit Direction
2022-06-07 271.86 $ 2022-08-09 298.83 $ 9.92%
2024-02-27 430.92 $ 2024-07-10 491.62 $ 14.09%
2024-03-05 415.44 $ 2024-06-04 474.95 $ 14.32%
2024-03-12 412.45 $ 2024-07-10 491.62 $ 19.2%
2024-05-07 410.24 $ 2025-08-05 374.98 $ 8.59%
2024-05-14 428.59 $ 2024-07-30 502.6 $ 17.27%
2024-10-01 469.76 $ 2024-12-19 396.64 $ 15.57%
2024-10-08 458.94 $ 2024-12-19 396.64 $ 13.57%
2024-10-15 484.3 $ 2024-12-19 396.64 $ 18.1%
2024-10-22 474.91 $ 2024-12-19 396.64 $ 16.48%
2024-12-13 463.73 $ 2025-03-17 513.76 $ 10.79%
2024-12-17 469.24 $ 2025-03-17 513.76 $ 9.49%
2024-12-24 408.18 $ 2025-08-08 366.54 $ 10.2%
2024-12-31 402.7 $ 2025-08-08 366.54 $ 8.98%
2024-12-31 402.7 $ 2025-08-08 366.54 $ 8.98%
2025-01-07 408.32 $ 2025-08-08 366.54 $ 10.23%
2025-01-14 411.66 $ 2025-08-05 374.98 $ 8.91%
2025-01-28 440.68 $ 2025-08-05 374.98 $ 14.91%
2025-05-28 445.1 $ 2025-08-05 374.98 $ 15.75%
2025-05-29 447.09 $ 2025-08-05 374.98 $ 16.13%
2025-05-30 442.05 $ 2025-08-05 374.98 $ 15.17%
2025-05-30 442.05 $ 2025-08-05 374.98 $ 15.17%
2025-05-30 442.05 $ 2025-08-05 374.98 $ 15.17%
2025-06-02 445.43 $ 2025-08-05 374.98 $ 15.82%
2025-06-03 446.48 $ 2025-08-05 374.98 $ 16.01%
2025-06-04 445.85 $ 2025-08-05 374.98 $ 15.9%
2025-06-05 443.82 $ 2025-08-05 374.98 $ 15.51%
2025-06-17 441.99 $ 2025-07-09 478.97 $ 8.37%
2025-06-20 440.87 $ 2025-07-09 478.97 $ 8.64%
2025-06-25 445.82 $ 2025-07-09 478.97 $ 7.44%
2025-06-26 443.4 $ 2025-07-09 478.97 $ 8.02%
2025-06-27 441.3 $ 2025-07-09 478.97 $ 8.54%
2025-06-27 441.3 $ 2025-07-09 478.97 $ 8.54%
2025-06-27 441.3 $ 2025-07-09 478.97 $ 8.54%
2025-06-30 445.2 $ 2025-07-09 478.97 $ 7.59%

How will the cost change for vertex pharmaceuticals incorporated (VRTX)

Purchasing a forecast for VERTEX PHARMACEUTICALS INCORPORATED (VRTX) can provide valuable insights for investors looking to earn and diversify their portfolios. By obtaining this forecast, you will gain access to crucial information about the changes in value and dynamics of VRTX in the coming months.

With our forecast, you will be able to anticipate how the cost of VRTX will fluctuate in December 2024, January 2025, February 2025, March 2025, and April 2025. This knowledge will empower you to make informed investment decisions and devise a winning strategy.

Whether the cost of VRTX will rise or fall during these months, our forecast will help you stay ahead of the market and capitalize on potential opportunities. By keeping a close eye on the release of new forecasts for VRTX, you can stay informed throughout the entire investment period.

Don't miss out on the chance to gain a competitive edge in the market. Purchase our forecast for VRTX now and unlock the potential for profitable investments and portfolio diversification.

The latest news about vertex pharmaceuticals incorporated

VRTXOctober 9, 2025Vertex Pharmaceuticals Incorporated: A Leader in Biotechnology Innovation  ~1 min.

Vertex Pharmaceuticals Incorporated, a biotechnology company known for its groundbreaking treatments for cystic fibrosis, has drawn the attention of top institutional investors....


VRTXAugust 15, 2025Vertex Pharmaceuticals Incorporated VRTX - Leading the Way in Rare Disease Treatments  ~1 min.

Vertex Pharmaceuticals Incorporated (VRTX) continues to make headlines as a leader in developing treatments for rare diseases....


VRTXAugust 8, 2025VERTEX PHARMACEUTICALS INCORPORATED Hits 10.2% Profit Target Forecast by QuantWave  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED has successfully achieved the price target forecast set by QuantWave, with a profit of 10.2% realized....


VRTXAugust 8, 2025VERTEX PHARMACEUTICALS Stock Hits Target Forecast with 8.98% Profit  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED has successfully reached the price target forecast set by QuantWave on August 8, 2025....


VRTXAugust 8, 2025VERTEX PHARMACEUTICALS Stock Hits Target Price with 10.23% Profit: QuantWave Forecast Success  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED stock recently reached its forecasted target price of 366.54 $, generating a profit of 10.23% for investors....


VRTXAugust 5, 2025VERTEX PHARMACEUTICALS INCORPORATED Successfully Hits Price Target Forecast with 16.01% Profit: A Triumph for QuantWave's Analytics  ~2 min.

VERTEX PHARMACEUTICALS INCORPORATED (VRTX) recently achieved the forecasted price target, as predicted by QuantWave's automated forecasting platform on 2025-06-03....


VRTXAugust 5, 2025VERTEX PHARMACEUTICALS INC Hits QuantWave Price Target with 14.91% Profit  ~2 min.

VERTEX PHARMACEUTICALS INCORPORATED has successfully achieved the price target forecast set by QuantWave, resulting in a profit of 14.91%....


VRTXAugust 5, 2025QuantWave Hits Bull's Eye with Vertex Pharmaceuticals Incorporated Price Target, Securing Profits of 16.13%  ~2 min.

Vertex Pharmaceuticals Incorporated, a renowned biotechnology company in the market, saw its stock price achieve a significant milestone recently as QuantWave's forecast signal on May 29, 2025, accurately predicted a short position movement. At the time of the signal, the stock was priced at $447.09, and just over two months later, on August 5, 2025, the target price of $374.98 was reached, result...


VRTXAugust 5, 2025VERTEX PHARMACEUTICALS INC: QuantWave Hits Target Forecast with Profit of 15.51%  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED has seen its stock hit the forecasted price target of 374.98 $ on 2025-08-05, yielding a profit of 15.51% for investors....


VRTXAugust 5, 2025QuantWave Forecast Accuracy: VERTEX PHARMACEUTICALS INC. Achieves Price Target with 15.17% Profit  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED has recently hit its price target forecast as predicted by QuantWave on May 30, 2025. The forecast signal indicated a short direction with a price of $442....